文献速递妇科生殖医学

微小RNA作为多囊卵巢综合征诊断标志物的系统评价与Meta分析

Dissecting the role of micro-RNAs as a diagnostic marker for polycystic ovary syndrome: a systematic review and meta-analysis.
PubMed 文献 · Fertil Steril · 2020-01-01

该系统评价与Meta分析检索至2019年5月的文献,评估微小RNA(miRNA)对多囊卵巢综合征(PCOS)的诊断价值。21项研究纳入系统评价,12项进入定量分析;miR-29a-5p和miR-320与PCOS显著相关,miR-29a-5p的ROC曲线下面积为0.95,提示其诊断性能较好。

要点

  • miR-29a-5p和miR-320与PCOS显著相关,漏斗图未提示发表偏倚。
  • miR-29a-5p的ROC曲线下面积为0.95,提示诊断价值优于其他miRNA。
  • 多种miRNA异常表达参与PCOS发病机制,但仅3种miRNA被3项以上研究报道。

核心结论

  • 多种miRNA的异常表达在PCOS发病机制中起重要作用。
  • miRNA对PCOS具有潜在诊断价值,miR-29a-5p诊断性能较好。

研究设计与样本

  • 系统评价与Meta分析,检索PubMed、Scopus和Google Scholar至2019年5月。
  • 初筛纳入21项研究、共79种miRNA,最终12项研究进入定量Meta分析、21项进入系统评价。
  • 采用随机效应模型计算汇总效应量,QUADAS量表评估质量,按组织类型行亚组分析。

主要发现

  • miR-29a-5p和miR-320与PCOS显著相关。
  • miR-29a-5p和miR-320的漏斗图未显示发表偏倚。
  • ROC分析显示miR-29a-5p的曲线下面积为0.95,为更优的PCOS诊断标志物。

关键数值与推荐

  • 截至2018年12月,仅miR-29a-5p、miR-320和miR-93在超过3项研究中被报道,故仅12项研究纳入定量分析。
  • miR-29a-5p的ROC曲线下面积为0.95。

临床怎么用

  • miR-29a-5p和miR-320可作为PCOS的潜在诊断标志物,但需进一步验证后方可用于临床。
  • miRNA异常表达为PCOS发病机制研究提供了新方向。

局限性

  • 截至2018年12月仅3种miRNA被超过3项研究报道,可定量合并的miRNA种类有限。
  • 检索截止至2019年5月,未纳入此后发表的研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the clinical diagnostic value and role of micro-RNAs (miRNAs) in the pathogenesis of polycystic ovary syndrome (PCOS). DESIGN: Systematic review and meta-analysis. SETTING: Not applicable. PATIENT(S): Patients were women of reproductive age with PCOS and controls. INTERVENTION(S): Summary odds ratio was calculated using a random effects model. MAIN OUTCOME MEASURE(S): Association of micro-RNAs with PCOS. METHOD(S): An electronic literature search was conducted using PubMed, Scopus, and Google Scholar databases to identify all relevant studies up to May 2019. A random effects model was used to conduct a meta-analysis. Fold change and P values were used to pool effect size. A funnel plot was used to assess publication bias. Quality score was calculated using the QUADAS scale. Subgroup analysis was based on tissue type. Odds ratios, 95% confidence intervals, and P values were estimated using meta-analysis. Metaregression was performed for correlating covariates with effect size. Area under the curve and receiver operating characteristic analysis was done to assess diagnostic performance accuracy of miRNAs in PCOS. RESULT(S): Twenty-one studies with a total of 79 miRNAs were included initially. Only three miRNAs (miR-29a-5p, miR-320, miR-93) are reported in more than three studies as of December 2018, so 12 studies were finally included in the quantitative analysis of meta-analysis and 21 studies were involved in the systematic review. The micro-RNAs miR-29a-5p and miR-320 were found to be significantly associated with PCOS. Funnel plot revealed an absence of publication bias for miR-29a-5p and miR-320. Receiver operating characteristic analysis with an area under the curve value of 0.95 proved miR-29a-5p to be the better diagnostic marker of PCOS. CONCLUSION(S): Aberrant expression of various miRNAs plays an important role in PCOS pathogenesis. Micro-RNAs hold potential diagnostic value for PCOS. These findings may offer new insights for PCOS pathogenesis research. PROSPERO REGISTRATION NUMBER: CRD42018106198.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Deswal R, Dang AS. Dissecting the role of micro-RNAs as a diagnostic marker for polycystic ovary syndrome: a systematic review and meta-analysis. Fertil Steril. 2020. PMID: 32192599. doi:10.1016/j.fertnstert.2019.11.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。